The benchmark indices witnessed major volatility during early afternoon trade. Banks stocks dragged the indices lower while metal and pharma scrips supported. The Nifty slipped below its 17,200 mark.
At 12:30 IST, the barometer index, the S&P BSE Sensex dropped 279.94 points or 0.49% at 57,404.88. The Nifty 50 index lost 71.90 points or 0.42% at 17,173.75.
The S&P BSE Mid-Cap index rose 0.23%. The S&P BSE Small-Cap index gained 0.10%.
The market breadth, indicating the overall health of the market, was negative. On the BSE, shares 1,467 rose and 1,788 shares fell. A total of 137 shares were unchanged.
Derivatives:
The NSE's India VIX, a gauge of market's expectation of volatility over the near term, fell 0.07% to 24.73. The Nifty 31 March 2022 futures were trading at 17,189.85, at a premium of 16.10 points as compared with the spot at 17,173.75.
The Nifty option chain for 31 March 2022 expiry showed maximum Call OI of 82.61 lakh contracts at the 18,000 strike price. Maximum Put OI of 103.32 lakh contracts was seen at 16,000 strike price.
Buzzing Index:
The Nifty Pharma index rose 1.13% to 13,722.35. The index gained 1.54% in two trading sessions.
Dr Reddy's Laboratories (up 3.96%), Lupin (up 3.38%), Aurobindo Pharma (up 3.31%), Glenmark Pharmaceuticals (up 2.15%) and Granules India (up 1.99%) were the gainers in the Pharma segment.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
